Consensus Applied BioCode Corporation

Equities

6598

KYG0488D1051

End-of-day quote Taiwan S.E. Other stock markets 23:00:00 13/05/2024 BST			5-day change	1st Jan Change
19.8 ^TWD	-0.50%		-1.00%	-21.74%

04-15	Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only	CI
03-21	Applied BioCode Announces CEO Changes	CI

Evolution of the average Target Price on Applied BioCode Corporation

Price target over the last 5 years

History of analyst recommendation changes

ba54a970ae561b.rebOVF-bBn46Q0ZRBGOLzL0LcXbqIexp-Xbj3Mt4OQo.-7SoJzbLVhJ5Jgxha1Tdvfs9IDmYW4YQtxiAv_MVe37OjZYME_9wSAg2Fw~80da50473e3b929835eed77f5540b317

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

19.8 TWD

Average target price

22 TWD

Spread / Average Target

+11.11%

High Price Target

22 TWD

Spread / Highest target

+11.11%

Low Price Target

22 TWD

Spread / Lowest Target

+11.11%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar